113 related articles for article (PubMed ID: 21349332)
1. SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.
Brellier F; Ruggiero S; Zwolanek D; Martina E; Hess D; Brown-Luedi M; Hartmann U; Koch M; Merlo A; Lino M; Chiquet-Ehrismann R
Matrix Biol; 2011 Apr; 30(3):225-33. PubMed ID: 21349332
[TBL] [Abstract][Full Text] [Related]
2. Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation.
Choi YA; Lim J; Kim KM; Acharya B; Cho JY; Bae YC; Shin HI; Kim SY; Park EK
J Proteome Res; 2010 Jun; 9(6):2946-56. PubMed ID: 20359165
[TBL] [Abstract][Full Text] [Related]
3. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression.
Gunnersen JM; Spirkoska V; Smith PE; Danks RA; Tan SS
Glia; 2000 Nov; 32(2):146-54. PubMed ID: 11008214
[TBL] [Abstract][Full Text] [Related]
4. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix.
Sarkar S; Yong VW
Carcinogenesis; 2010 Feb; 31(2):311-7. PubMed ID: 19965895
[TBL] [Abstract][Full Text] [Related]
5. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
6. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
7. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
8. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
[TBL] [Abstract][Full Text] [Related]
10. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
13. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
15. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression.
Huang JY; Cheng YJ; Lin YP; Lin HC; Su CC; Juliano R; Yang BC
J Immunol; 2010 Aug; 185(3):1450-9. PubMed ID: 20622113
[TBL] [Abstract][Full Text] [Related]
17. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide-tenascin interaction mediates binding to the extracellular matrix and endocytic uptake of liposomes in glioma cells.
Shao K; Hou Q; Go ML; Duan W; Cheung NS; Feng SS; Wong KP; Yoram A; Zhang W; Huang Z; Li QT
Cell Mol Life Sci; 2007 Feb; 64(4):506-15. PubMed ID: 17279316
[TBL] [Abstract][Full Text] [Related]
19. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.
Zagzag D; Friedlander DR; Dosik J; Chikramane S; Chan W; Greco MA; Allen JC; Dorovini-Zis K; Grumet M
Cancer Res; 1996 Jan; 56(1):182-9. PubMed ID: 8548761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
